|Published||Report Code||Available Format||Pages|
HIV diagnosis refers to the test performed to detect the presence of human immunodeficiency virus (HIV) in humans. HIV attacks the immune system targeting CD4 cells, also known as T cells. T-cells helps the immune system to fight against infections. HIV weakens the immune system of an infected individual by reducing the number of T-cells leading to acquired immunodeficiency syndrome (AIDS). AIDS is the advanced stage of HIV infection, and not everyone suffering from HIV infection has AIDS. As reported by the Centers for Disease Control and Prevention (CDC), people diagnosed with AIDS have their CD4 cell count below 200 cells/mm, and have high viral load. The global HIV diagnosis market has been segmented on the basis of product, application and end user.
On the basis of product, the global market has been segmented into consumables, instruments and software and services used for the diagnosis of HIV. Consumables segment has been the largest segment in the global HIV diagnosis market. Consumables include assays, kits, reagents and others. These kits are available as complete and convenient packed test systems and include a standard operating procedure (SOP). A patient has to follow the instructions carefully to get the desired results. Kits offer rapid, easy to use, sensitive, and reliable detection of HIV infection.
GLOBAL HIV DIAGNOSIS PRODUCTS MARKET SNAPSHOT (2016)
On the basis of type of test, the global HIV diagnosis market has been segmented into antibody test, viral load, CD4, early infant diagnosis and viral identification. Antibody test has been the largest segment in the global market. It further involves HIV-1 screening test, HIV-1 antibody confirmatory test and HIV-2 & group O test.
On the basis of end user, the market has been segmented into diagnostic laboratories, hospitals, research institutes and others. Others comprises of the gene banks, cell banks, biotechnology and pharmaceutical companies and home care settings. Diagnostic laboratories have been the largest end user of the global market.
The global HIV diagnosis market is expected to witness a CAGR of 10.6%, during the forecast period. Rising prevalence of HIV/AIDS, growing awareness leading to high number of blood donations and blood transfusions, and advantageous features of point of care instruments and kits are some of the key drivers for the global HIV diagnosis market growth. Increasing healthcare expenditure on HIV and related activities further supports the market growth. On the other hand, the market has been facing certain challenges such as high cost of automated HIV diagnosis procedures and lack of skilled professionals, which may impede its growth, during the forecast period. Growing HIV diagnosis market in emerging economies and increase in the popularity of home-based HIV diagnosis devices are presenting a lucrative market opportunity for the players operating in the global HIV diagnosis market.
According to the data published by the Joint United Nations Programme on HIV/AIDS (UNAIDS), the prevalence of HIV/AIDS increased by 2.8 million from year 2011 to 2015, reaching approximately 36.7 million HIV positive people globally. The increasing incidence of the HIV/AIDS would mean more number of people taking the HIV/AIDS diagnosis tests in the future, thereby driving the growth in global HIV diagnosis market.
The increased participation of government associations has raised awareness regarding blood donations and blood transfusions, globally. Some of the major associations including the WHO, International Federation of Red Cross and Red Crescent Societies (IFRC), AABB (formerly known as the American Association of Blood Banks) and American Red Cross have supported blood donor programs and encouraged people to donate blood and blood components. Moreover, various government initiatives have been launched by these associations to increase awareness among people about blood donations. These government associations and initiatives have boosted blood collections through voluntary donation around the world. According to WHO, approximately 92 million blood donations were reported annually in 2011 and the number reached to 108 million in 2014, globally. The compromised use of sterilized needles during blood transfusion leads to increased risk of HIV infection thus, serving as a major driver for the growth of the global HIV diagnosis market. The advent of point-of-care instruments and kits for the diagnosis of HIV infection has boosted the rate of diagnosis of people living with HIV due to their several advantages over the old laboratory testing. Also, the healthcare expenditure on HIV and related activities has increased in many countries over the past few years, especially for the purpose of alleviating the potential epidemic situation of HIV in many low- and middle-income as well as developing countries. This in turn is expected to drive the growth of HIV diagnosis market in these countries.
Some of the key players in the global HIV diagnosis market include Siemens AG, F. Hoffman La Roche Ltd., Danaher Corporation, Abbott Laboratories, Ltd., Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson & Company, Alere Inc., Bio-Rad Laboratories and Hologic Inc.
P&S Market Research offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes: